Wang, Q., Liu, P., Spangle, J. M., Von, T., Roberts, T. M., Lin, N. U., . . . Zhao, J. J. (2015). PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers. Oncogene.
Styl ChicagoWang, Qi, Pian Liu, Jennifer M. Spangle, Thanh Von, Thomas M. Roberts, Nancy U. Lin, Ian E. Krop, Eric P. Winer, a Jean J. Zhao. "PI3K-p110α Mediates Resistance to HER2-targeted Therapy in HER2+, PTEN-deficient Breast Cancers." Oncogene 2015.
Citace podle MLAWang, Qi, et al. "PI3K-p110α Mediates Resistance to HER2-targeted Therapy in HER2+, PTEN-deficient Breast Cancers." Oncogene 2015.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..